Stock

Oracle, Salesforce dip among Thursday’s market cap stock movers

Thursday’s market has seen notable movements across a spectrum of stocks, with some of the largest companies experiencing declines, while others in the large-cap space are on the rise. Mega-cap stocks like Oracle Corp (NYSE:ORCL) and Salesforce Com (NYSE:CRM) have seen a downturn, while large-cap players such as MicroStrategy Inc (NASDAQ:MSTR) are bucking the trend with impressive gains. Here’s a look at some of the most significant stock movers of the day, from mega-caps to small caps.

Mega-Cap Movers (Market Cap $200B+):

Oracle Corp (ORCL): -4.03%
Salesforce Com (CRM): -3.84%
Avago Technologies (NASDAQ:AVGO): -3.08%
Servicenow Inc (NYSE:NOW): -2.68%
Adobe Sys Inc (NASDAQ:ADBE): -2.21%

Large-Cap Stock Movers (Market Cap $10B-$200B):

Dell Inc (NYSE:DELL): -12.25%
Hewlett-pack (NYSE:HPQ): HP stock downgraded to Hold by HSBC on weak 1QFY25 outlook and rising commodity costs; -11.36%
MicroStrategy Inc (MSTR): +9.94%
Autodesk Inc (NASDAQ:ADSK): -8.59%
Nutanix Inc (NASDAQ:NTNX): Nutanix to Present at Upcoming Investor Conference; -7.81%
BeiGene (NASDAQ:BGNE): +7.31%
Reinvent Technology Partners Y (AUR): +7.27%
Li Auto Inc (NASDAQ:LI): American Lithium Reports Results of Annual General and Special Meeting; +6.78%
IBIT NASDAQ (IBIT): +6.44%
FBTC NYSE (FBTC): +6.37%

Mid-Cap Stock Movers (Market Cap $2B-$10B):

SVF Investment 3 (SYM): -35.87%
Iris Energy (IREN): +29.71%
Arrowhead Research Corp (NASDAQ:ARWR): +24.23%
Urban outfitters (NASDAQ:URBN): +18.31%
Hut 8 Mining PK (HUT): +16.5%
HCM Acquisition (MRNO): +16.17%
Good Works Acquisition (CIFR): +14.56%
MSTU (MSTU): +13.93%

Small-Cap Stock Movers (Market Cap $300M-$2B):

Advanced Photonix Inc (API): +33.97%
ETHU (ETHU): +18.79%
Golden Bull (BTBT): +18.45%
Fate Therap (NASDAQ:FATE): +18.28%
Kingsoft Cloud Holdings Ltd (KC): +17.42%
Immunome Inc (NASDAQ:IMNM): +16.83%
Wowo Ltd (MFH): -16.32%
Semler Scientifc (NASDAQ:SMLR): +16.06%
Applied Therapeutics Inc (NASDAQ:APLT): FDA declines approval for Applied Therapeutics’ Galactosemia drug; -16.06%

For real-time, market-moving news, join Investing Pro.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

This post appeared first on investing.com

You May Also Like

Editor's Pick

Former president Donald Trump and his allies have filed hundreds of lawsuits, with more to come, seeking to tighten voting rules or disqualify voters....

Economy

LONDON (Reuters) – Bank of England interest rate-setter Megan Greene said she still believed the central bank should take a cautious approach to cutting...

Editor's Pick

Sister Stephanie Schmidt had a hunch about what her fellow nuns would discuss over dinner at their Erie, Pennsylvania, monastery on Wednesday night. The...

Latest News

Tunisians voted Sunday in an election expected to grant President Kais Saied a second term, as his most prominent detractors, including one of the candidates challenging...

Disclaimer: beneficialinvestmentnow.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

Copyright © 2024 beneficialinvestmentnow.com

Exit mobile version